Clinical Trial

18F-PSMA PET/CT Versus CT Alone in Assessment of Prostatic Cancer Patients

Name: 18F-PSMA PET/CT Versus CT Alone in Assessment of Prostatic Cancer Patients — clinical trial record (NCT07485881)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

To compare the diagnostic performance of 18-F PSMA PET/CT and CT alone in initial staging, assessment of therapy response, as well as evaluation of biochemical recurrence of prostatic cancer patients The main question it aims to answer is: Does 18-F PSMA PET/CT have a superior role over CT in evaluation of prostatic cancer patients?

Trial Details

NCT Number	NCT07485881
Lead Sponsor	Assiut University
Conditions	Prostate Cancer, Prostate Cancer Metastatic, Prostate Cancer Recurrent
Enrollment	59 participants
Start Date	2026-05-01
Primary Completion	2028-05 (estimated)
Study Completion	2028-06 (estimated)
Updated on ClinicalTrials.gov	2026-03-20